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In humans a substantial variability in biologic response to (1-OHP) in urine, and genotypes for biotransformation PAHs is to be expected because of interindividual differences enzymes involved in PAH metabolism. The aim was to in the activity of the enzyme systems involved in the formation evaluate the correlation between external exposure and of reactive intermediates and their detoxification through biomarkers of exposure and to investigate to what extent conjugation and excretion. Enzyme polymorphisms have been genetic polymorphism in metabolic enzymes can explain suggested to explain interindividual differences in the rate interindividual variation in urinary 1-OHP levels. DNA of metabolism and activation/deactivation of PAH-derived was prepared from blood samples from 98 potroom workers carcinogens. The general mechanism of metabolic activation and 55 controls and altogether eight polymorphisms in the of PAHs, such as benzo [a] pyrene (B[a]P), is via the formation CYP1A1, mEH, GSTM1, GSTP1 and GSTT1 genes were of bay-region dihydrodiol epoxides e.g. benzo [a] pyrene-7,8-analyzed. The 1-OHP excretion was found to correlate dihydrodiol-9,10-epoxide (BPDE), via cytochrome P450 significantly (P ≤ 0.005) to the exposure. The interindividual (CYP) and epoxide hydrolase. Metabolic activation of PAH in difference in excretion of 1-OHP was vast (>100-fold) and human lung has mainly been ascribed to CYP1A1, an inducible univariate and multivariate regression analyses were used extrahepatic enzyme with aryl hydrocarbon hydroxylase (AHH) to find the variables that could determine differences in activity. In addition to CYP1A1, other CYP isozymes, such excretion. The variation could, to some degree, be explained as 1A2, 1B1 and 3A4 may also participate in the metabolic by differences in exposure to airborne particulate-associactivation of PAHs (3-5). Further metabolism results in deacated PAHs, the use of personal respiratory protection tivation of PAH derivates through glutathione conjugation by devices, smoking habits and genetic polymorphisms in the glutathione S-transferases (GSTs). GSTP1, the most abundant cytochrome P450 1A1, GSTM1 and GSTT1 enzymes. The GST in lung, and GSTM1, have the ability to detoxify epoxides part of the variance that could be explained by differences such as BPDE, whereas GSTT1 preferentially conjugates in biotransformation genotypes seemed to be of the same smaller compounds. Other detoxifying enzymes are UDPorder of magnitude as the variance explained by differences glucuronosyl transferase and sulfotransferase, which conjugate PAH metabolites that possess hydroxyl groups. in exposure. In the control group as well as in the occupaIncreased risk of lung cancer in smokers has been associated tionally exposed group, the highest 1-OHP levels were with high AHH inducibility and a positive correlation between observed in individuals carrying the CYP1A1 Ile/Val geno-AHH activity, and the level of BPDE adducts has been observed type who were also of the GSTM1 null genotype. The in lung (6-8 and North American populations (9,10). There is also a growing
The study was performed in a Swedish aluminum production plant where number of studies that link the mutations in the CYP1A1 gene the vertical-stud Söderberg process is being used. Workers were recruited exclusively from the potroom where the highest concentration of PAH was to increased susceptibility to DNA damage. The alleles carrying expected. As a control group, postmen and city council employees of the the MspI mutation or the Ile→Val mutation, the CYP1A1*2A same town were recruited. The final study group consisted of 98 potroom or CYP1A1*2B alleles, were more commonly found in PAHworkers and 55 controls, all males. They were interviewed by a trained physician with respect to health status, smoking habits, alcohol consumption, exposed individuals with high levels of DNA adducts derived occupational history and use of respiratory protection devices. Thirty-two from anti-BPDE (11). These alleles were also associated with percent of the potroom workers and 22% of the control subjects were current increased occurrence of p53 mutations in tumor tissue (12) smokers. In all, 20% of the workers always (ജ90% of the time), 30% and have, in some studies but not all, been associated with sometimes (1-89% of the time) and 50% never wore protective airstream helmets or filter masks. A detailed description of the plant and characteristics increases in the catalytic activity of the enzyme and with of the study population and the controls has been given elsewhere (2).
higher AHH inducibility (13).
Sample collection
A number of polymorphisms within the microsomal epoxide Sampling of airborne PAHs, urine and blood took place during Februaryhydrolase (mEH) gene have been identified but only two have April 1995 . Particulate-associated and gaseous-phase PAHs in the breathing been found to alter the enzymatic activity (14). In vitro zone were determined by personal air sampling during a full workday for all experiments suggest that the Tyr113→His exchange in exon the workers and five of the controls. For daytime potroom workers, urine samples were collected in the morning before work and immediately after 3 is associated with decreased mEH activity, whereas the work on the fourth or fifth working day. For the shift workers, urine samples substitution of His139 with Arg in exon 4 is associated with were collected in the morning before the afternoon shift and in the late increased mEH activity. Whether these mEH polymorphisms evening after the shift on the sixth working day. For the control subjects, contribute to interindividual differences in susceptibility to urine samples were collected in the morning before work. Urine samples were also collected after work for the five controls in which airborne PAH exposure carcinogens, such as PAHs, has not yet been clearly established.
was measured. Blood samples were obtained from all workers and controls.
The most studied human GST, GSTM1, is lacking in~50% The GSTT1 polymorphism is also caused by a deletion that elsewhere (2). results in total lack of gene product. In a Swedish population
Analyses of 1-OHP in urinẽ
11% were found to lack GSTT1 activity (17, 18) , whereas
Excretion of 1-OHP in urine was measured as described previously (29) . slightly higher frequencies have been reported in other CaucaUrine was submitted to enzymatic hydrolysis followed by a purification step. Samples were analyzed by HPLC with fluorescence detection (23) .
sian populations (19) . The GSTP1 gene was recently found to
Concentrations of 1-OHP were adjusted to creatinine to compensate for be polymorphic in amino acid positions 104 and 113 (20) .
variations in urine flow.
Residue 104 lies in close proximity to the active site and it
Identification of genotypes
has been shown that the Val variant has altered specific activity DNA from lymphocytes was prepared using a commercial kit based on solid and affinity for electrophilic substrates (21, 22) . With respect phase, anion-exchange chromatography (Qiagen Genomic-tips 100/G).
to lung cancer in humans and exposure to PAH-containing
The MspI polymorphism in the 3Ј-flanking region (T6235C) of the CYP1A1 gene was analyzed essentially as described by Hayashi et al. (30) . The material, the results from studies on GSTP1 and GSTT1 A4889G polymorphism in exon 7 of CYP1A1 that results in an Ile→Val polymorphisms are too limited and variable to allow any amino acid replacement at residue 462 was analyzed using an allele-specific definite conclusion.
PCR method as described previously (31) . GSTM1 genotyping was carried As a biomarker of human PAH exposure, 1-OHP has gained out essentially according to methods described by Brockmöller et al. (32) . GSTT1 genotypes were determined as described previously (18, 33) . β-Actin a strong position (23) (24) (25) . Pyrene is one of the most abundant was used as positive control in the GSTM1 and GSTT1 assays to verify the PAHs in coal tar, and the highly fluorescent pyrene metabolite presence of amplifiable DNA. Analysis of the GSTP1 polymorphisms resulting 1-OHP can be quantified in urine by HPLC. Levels of in an Ile→Val substitution at residue 104 in exon 5 and an Ala→Val particulate-associated pyrene correlated well with levels of substitution at residue 113 in exon 6 were performed as described previously (1). In the same publication a detailed protocol for the allele-specific method total PAH in breathing zone air. Urinary 1-OHP gives a more for detection of the Tyr-His polymorphism at residue 113 in exon 3 of mEH accurate assessment of total PAH exposure from all exposure gene was given. The His-Arg polymorphism at residue 139 in exon 4 of mEH routes, including dermal absorption, than PAH levels in air gene was determined as described by Hassett et al. (14) . The PCR primers (26) . CYP1A1 and other PAH-metabolizing CYPs metabolize used are shown in Table I. pyrene to 1-OHP, which is excreted in the urine as the Statistical analyses corresponding glucuronide. It has been estimated that~30%
Group differences in concentration of PAH and 1-OHP levels were tested with Wilcoxon rank-sum test. In some statistical analyses the urinary 1-OHP of retained pyrene after PAH inhalation is excreted in urine in data were stratified by low (less than or equal to the median total particulate the form of 1-OHP (27 of 1-OHP in urine in PAH exposed workers and in unexposed
The independent variables consisted of the current number of cigarettes controls. Other factors that may influence the excretion of 1-smoked per day, smoking (yes ϭ 1 or no ϭ 0), age, total particulate-associated OHP such as age, tobacco smoking and use of protection PAH (ln transformed), total gaseous phase PAH (ln transformed) and use of respiratory protection devices [always (ജ90% of the time) ϭ 2; sometimes devices were also analyzed in detail. Exposure data for total particulate PAHs and pyrene is missing 1 and Ala/Ala ϭ 0; GSTT1 -/-ϭ 1 and ϩ/ϩ or ϩ/-ϭ 0. Independent from four exposed and two control subjects. Data for B[a]P variables with a P-value Ͻ0.1 in the univariate analysis were included in the is missing from two more subjects, one exposed and one multiple regression analysis. Independent variables that turned out to be noncontrol. Exposure data for the gaseous phase is missing from significant in the multiple regression analysis were excluded by a stepwise procedure. Explanatory values were calculated for significant independent three exposed subjects (Table II) .
variables in the univariate model and for the multivariate model in whole.
The Spearman correlation coefficients for pyrene and total PAH concentration in air were 0.79 (P Ͻ 0.001) and 0.93 Results (P Ͻ 0.001) for gaseous and particulate-associated phases, respectively (Table III) . A strong positive correlation (r s ϭ Air monitoring 0.87, P Ͻ 0.001) was also found between pyrene and B[a]P. The time-weighted average exposures to pyrene, B[a]P and An extensive presentation of the work environment analyses total PAH in potroom workers and control subjects are preis given elsewhere (2). sented in Table II . The concentration of total particulate-1-OHP in urine associated PAHs among the potroom workers ranged from 1.42 to 270 µg/m 3 (median 15.8) as compared with 0.01-0. 36 The median concentration of urinary 1-OHP sampled before work was 3.43 µmol/mol creatinine (range 0.07-26.6) in (median 0.11) for control subjects. Corresponding figures for total PAHs in the gaseous phase were 0.13-131 µg/m 3 (median potroom workers and 0.11 (range 0.02-0.99, P Ͻ 0.001) in the controls (Table II) . In the potroom workers, the level of 16.3) in workers and Ͻ0.01-0.41 (median 0.20) in control subjects. Irrespective of gaseous or particulate-associated form, 1-OHP was increased to a median of 4.31 µmol/mol creatinine (range 0.09-17.7) immediately after work. The interindividual the median concentrations of each PAH and total PAH were significantly higher in potroom samples than in control samples. change in excretion over the workday was, however, substantial. The majority of the workers belonged to the afternoon The median concentration of pyrene in potroom samples was 1.56 µg/m 3 (range 0.01-9.52) in the gaseous phase and 1.11 shift (14:00-22:00). The morning urinary 1-OHP level seemed to be influenced to a large extent by exposure during the (range 0.07-34.4) in the particulate-associated phase. Thus, previous evening shift. Thus, all further statistical analyses in level of 1-OHP was seen in the subjects carrying the CYP1A1 potroom workers are based on measurements of urinary 1-(exon 7) Val allele. The median concentration of 1-OHP in OHP sampled after work. For controls, the statistical analyses urine was 7.47 µmol/mol creatinine (range 2.36-17.7) in the on 1-OHP levels derived from urine sampled before work seven subjects with the Ile/Val genotype compared with 4.28 (n ϭ 54) due to the low number of after-work samples collected (range 0.09-13.9) in subjects with the Ile/Ile genotype. Also, (n ϭ 5). The results from the analyses for 1-OHP in urine in in the control subjects, the influence of the CYP1A1 Val allele samples collected before work are missing in four exposed was observed. Subjects carrying the CYP1A1 Ile/Val genotype subjects and in one control subject and, in the samples collected had significantly increased 1-OHP levels in urine. The median after work, data are missing for one exposed subject.
concentration in the seven subjects with the Ile/Val genotype All individual PAHs, with the exception for particulatewas 0.17 µmol/mol creatinine (range 0.08-0.50), and in those associated methylphenanthrenes and anthracene, were weakly with the Ile/Ile genotype it was 0.10 (range 0.02-0.99), P ϭ but significantly correlated to urinary 1-OHP collected after 0.04. In the control group, GSTT1 did not influence the 1-work. Moderate but significant correlations were found between OHP levels. both gaseous (r s ϭ 0.25, P ϭ 0.016) and particulate-associated
In the potroom workers, when divided into a low exposure (r s ϭ 0.34, P ϭ 0.001) pyrene and 1-OHP (Table III) . Similar group (less than or equal to the median total particulate PAH) correlations were found for total PAH in gaseous phase and and a high exposure group (greater than median total particulate particulate-associated form (r s ϭ 0.28, P Ͻ 0.005 and r s ϭ PAH), some significant differences in 1-OHP excretion between 0.37, P Ͻ 0.001, respectively). different CYP1A1 genotypes were detected (data not shown).
In the low exposure group, 1-OHP levels were significantly Influence of smoking, use of protection devices and genotypes higher in the eight subjects with CYP1A1 (MspI) T/C or C/C on 1-OHP excretion genotypes (median 4.60 µmol/mol creatinine, range 3.44-9.09) In the control subjects there was a significant difference in the compared with 39 subjects with the C/C genotype (median median concentration of urinary 1-OHP in samples taken 3.55, range 0.09-8.70, P ϭ 0.02). The three subjects in the before work between smokers (0.17 µmol/mol creatinine, range high exposure group with the rare CYP1A1 Ile/Val genotype 0.09-0.99) and non-smokers (0.10, range 0.02-0.50, P Ͻ had significantly higher 1-OHP levels (median 10.5 µmol/mol 0.001). There was no significant difference in the median 1-creatinine, range 9.77-17.7) than those with the common Ile/ OHP levels between smokers and non-smokers among the Ile genotype (n ϭ 43, median 5.08, range 0.12-13.9, P ϭ exposed (P Ͼ 0.5).
0.02). An increase in the 1-OHP level was found also for the A lower median concentration of after-work urinary 1-OHP two subjects with the Ile/Val genotype in the low exposure was observed among potroom workers who used respiratory group compared with the carriers of the Ile/Ile genotype. protection devices (filter or airstream) at least 90% of the time Univariate regression analyses with urinary 1-OHP sampled (3.16 µmol/mol creatinine, range 0.09-7.84) compared with after work as the dependent variable, and smoking, age, workers who used the protection equipment less frequently airborne PAH exposure, usage of respiratory protection devices (1-89% of time, 4.71, range 0.12-10.9) or not at all (4.40, and metabolic genotypes for CYP1A1, mEH, GSTM1, GSTT1 range 0.09-17.7). The effect of respiratory protection on 1-and GSTP1 as the determining variables, were performed. OHP, stratified by PAH exposure (particular phase), is shown These analyses showed that the total particulate-associated in Table IV . At lower than median PAH exposures the most PAH level, use of protection devices and genotype for the pronounced protection was observed.
CYP1A1 (exon 7) gene significantly influenced the concentraThe impact of genetic polymorphisms on the concentration tion of urinary 1-OHP (P Ͻ 0.05 for all). In addition, the of urinary 1-OHP is shown in Table V . Except for GSTT1, current number of cigarettes smoked per day and genotypes where subjects lacking this gene had lower 1-OHP levels (3.60 for the GSTM1 and GSTT1 genes also had a possible influence versus 4.47 µmol/mol creatinine), no statistically significant on the level of 1-OHP in urine (P Ͻ 0.1 for all). The CYP1A1 genotype-related differences in 1-OHP levels in potroom Ile/Val genotype, the GSTM1 (-/-) genotype and the GSTT1 workers were found when the exposure levels were not taken into consideration. However, a non-significant elevation in the (ϩ/ϩ or ϩ/-) genotypes were associated with increased significantly to the prediction of urinary 1-OHP (P ϭ 0.06).
The predictor variables that determine the concentration of urinary 1-OHP,
The explained variance, r 2 , of the model with the five remaining after work, in potroom workers are shown.
determinants was, however, only 0.28. In a corresponding a Variables described in Materials and methods.
univariate regression analysis for controls with urinary 1-OHP b Regression coefficient.
sampled before work as dependent variable, the independent variables smoking and number of cigarettes smoked per day were the only determinants that significantly influenced the 1-and GSTM1 genotypes; Ile/Ile, ϩ/ϩ or ϩ/-(0.10 µmol/ mol creatinine, range 0.02-0.18); Ile/Ile, -/-(0.11 µmol/mol OHP level (P ഛ 0.002 for both).
The influence of combined genotypes for CYP1A1 (exon 7) creatinine, range 0.05-0.99); Ile/Val, ϩ/ϩ or ϩ/-(0.15 µmol/ mol creatinine, range 0.13-0.17) and Ile/Val, -/-(0.17 µmol/ and GSTM1, both significant predictors in the multivariate analysis, on the 1-OHP levels are presented in Figure 1a and b. mol creatinine, range 0.08-0.50). The difference was statistically significant between subjects with the Ile/Ile ϩ/ϩ or ϩ/-Slight differences in the median concentration of 1-OHP were observed in control subjects with the combined CYP1A1 genotypes and the Ile/Val -/-genotype, P ϭ 0.04 (Figure 1a) . The observed differences were not explained by smoking as high sensitivity of the analytical method and because it none of the subjects with the CYP1A1 Ile/Val genotype takes into account all exposure routes. Background levels are were smokers.
normally low but an influence from environmental PAH Aluminum smelter workers with the combined CYP1A1 Ile/ contamination and smoking can be detected. Median 1-OHP Val and GSTM1 (-/-) risk genotypes had substantially higher values of 0.03 and 0.09 µmol/mol creatinine have previously urinary 1-OHP levels compared with all other genotype combeen reported in Swedish non-smokers and smokers, respectbinations (P Ͻ 0.05 for all, Figure 1b) . The median concentraively (23) . In the present investigation smoking control subjects tion was 10.1 µmol/mol creatinine (range 7.47-17.7) in the showed a median 1-OHP value of 0.17 µmol/mol creatinine. four workers with the Ile/Val -/-genotype, whereas the median Canadian residents, living Ͻ500 m from a Söderberg aluminum concentrations were between 3.16 and 4.36 (range 0.09-13.9) reduction plant, showed significantly increased excretion of 1-in subjects with the other genotype combinations. Further OHP compared with control subjects living in another industrial analyses of the impact of combined genotypes on the 1-OHP town (37). In occupational settings the 1-OHP content in urine levels stratified by external PAH exposure and use of protection may be increased 10-100-fold. Coke ovens, carbon electrode devices were not possible due to the limited number of workers production plants, tar distilleries, aluminum smelters and carrying the Val allele. It should be noted that the four subjects creosote impregnation plants represent workplaces where high with the Ile/Val -/-genotype had a higher PAH exposure urinary 1-OHP levels are often observed (24) . In this study compared with subjects with other genotype combinations but the concentration of urinary 1-OHP sampled after work ranged the differences between median values for total PAHs as well up to 17.7 µmol/mol creatinine (median 4.31) in the potroom as for pyrene were not statistically significant. The subjects workers. Earlier biological monitoring of nine potroom workers with the genotype Ile/Val -/-all belonged to the group that within the same plant showed that 1-OHP ranged up to 3.57 never use respiratory protection devices.
µmol/mol creatinine (median 2.1) (23) . Thus, the decreasing airborne PAH concentrations in this plant during the last years Discussion have not resulted in decreased excretion of urinary 1-OHP.
In an in vitro study with human lung microsomes, the rate According to epidemiological studies, aluminum production of oxidative metabolism of pyrene showed wide interindividual plant workers are at increased risk of lung and bladder variation with the highest activity observed in smokers (38) . cancer (34, 35) . Several indicators for PAH exposure have been
The pyrene 1-hydroxylase activity was 70% inhibited by suggested, but so far B[a]P levels in the air have been most monoclonal antibodies raised against rat CYP1A1, which commonly used. The quantitative risk estimates that exist for indicates the importance of the CYP1A1 enzyme for pyrene PAHs have been based on epidemiological data from cokemetabolism in the lung. Gene-environment interactions on the oven workers using B[a]P as the indicator substance. The excretion of 1-OHP were confirmed in the present study, where WHO unit risk estimate for humans indicates that a lifetime certain CYP1A1 (exon 7), and GSTM1 genotypes were found exposure to 1 ng/m 3 of B[a]P would lead to nine extra cancer to have a limited, but significant, influence on 1-OHP excretion. cases in 100 000 exposed individuals (36) . Thus, the PAH The CYP1A1 (MspI) polymorphism was also analyzed in a exposure level observed in aluminum smelting plants (between study of 80 coke-oven workers from Taiwan (39) . It was found 20 and 23 500 ng/m 3 B[a]P in this study) are not negligible, that the subjects with the homozygous variant genotype had a and appropriate and sensitive biomarkers of exposure are 2-fold higher post-shift 1-OHP level than the grouped wildwarranted.
type and heterozygous genotypes. Pan et al. (40) reported, on The urinary level of the pyrene metabolite 1-OHP has been suggested as a biomarker of PAH exposure because of the the other hand, no influence of GSTM1 or CYP1A1 (exon 7)
polymorphisms on 1-OHP excretion in a study on 99 Chinese risk for lung cancer in GSTM1-deficient subjects (31, 44, 45) . In summary it can be concluded that the urinary level of 1-coke-oven workers. They observed no correlations between DNA adducts and either total PAH exposure or urinary 1-OHP is a sensitive indicator of human exposure to PAHs and that in addition to being a marker of exposure it may also to OHP, but demonstrated a significant correlation between DNA adduct levels and urinary 1-OHP in workers with the CYP1A1 some extent reflect the interindividual variation in susceptibility to PAHs. Ile/Val or Val/Val genotypes (40) . The PAH levels were in general higher in that study compared with the PAH levels in the present study. In a study on police officers in Italy exposed
